Comparison of Double Kissing Culotte Stenting With Double Kissing Crush Stenting for True Bifurcation Lesions

NACompletedINTERVENTIONAL
Enrollment

328

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

December 31, 2020

Study Completion Date

December 30, 2021

Conditions
Coronary Heart Disease
Interventions
DEVICE

Resolute stents

zotarolimus-eluting Resolute stents made by Medtronic Vascular, Inc (http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/Recently-ApprovedDevices/ucm294951.htm).

Trial Locations (12)

100024

Peking University First Hospital, Beijing

100029

Beijing Anzhen Hospital, Beijing

200030

SHANGHAI CHEST Hospital, Shanghai

200032

ZHONGSHAN hospital, Shanghai

200127

Renji Hospital Shanghai Jiaotong University, Shanghai

210006

Nanjing First Hospital, Nanjing

210009

Southeast University Zhongda Hospital, Nanjing

310016

Sir Run Run Shaw Hospital, Hangzhou

350001

Department of Cardiology, Union Hospital, Fujian Medical University, Fuzhou

362002

QUANZHOU First Hospital, Quanzhou

Unknown

East hospital of Tongji university, Shanghai

Xinhua Hospital Affiliated of Shanghai Jiao Tong University, Shanghai

All Listed Sponsors
collaborator

Jetmed(Beijing)Co.,Ltd.

UNKNOWN

lead

Fujian Medical University

OTHER

NCT01735656 - Comparison of Double Kissing Culotte Stenting With Double Kissing Crush Stenting for True Bifurcation Lesions | Biotech Hunter | Biotech Hunter